Table 2 Description of study sample
Variable | Category/Range | N | % | M | SD |
|---|---|---|---|---|---|
Total Sample | 100 | ||||
Age | 24–87 | 55.5 | 15.9 | ||
Female gender | 81 | 81.0 % | |||
Ethnicity | White British | 44 | 44.0 % | ||
Asian | 10 | 10.0 % | |||
Black | 20 | 20.0 % | |||
White Other | 14 | 14.0 % | |||
Other | 12 | 12.0 % | |||
Mental Health | |||||
Depression Total | 0–6 | 2.2 | 2.0 | ||
Depression Category | No symptoms | 57 | 57.0 % | ||
Some symptoms | 16 | 16.0 % | |||
pMDD | 27 | 27.0 % | |||
Anxiety Total | 0–6 | 2.0 | 1.8 | ||
Anxiety Category | No symptoms | 63 | 64.3 % | ||
Some symptoms | 13 | 13.3 % | |||
pGAD | 22 | 22.5 % | |||
Psychological Distress | pGAD or pMDD | 34 | 34.0 % | ||
Physical Health | |||||
Disease duration (years) | 0.8–34.9 | 6.5 | 6.4 | ||
Fatigue | 0–100 | 54.4 | 25.8 | ||
Pain | 0–100 | 50.5 | 25.9 | ||
HAQ | 0–3 | 1.3 | 0.8 | ||
TJC | 0–28 | 5.2 | 6.4 | ||
SJC | 0–16 | 2.0 | 2.8 | ||
ESR | 1–121 | 24.1 | 23.6 | ||
PGA | 1–100 | 49.2 | 28.2 | ||
DAS28 | 0.1–7.5 | 3.9 | 1.7 | ||
SF-36 (normed subscale scores shown in brackets) | |||||
Physical Function (PF) | 0–100 (13.1–56.8) | 42.3 (31.6) | 28.9 (12.6) | ||
Role Physical (RP) | 0–100 (26.0–55.6) | 28.6 (34.4) | 39.5 (11.7) | ||
Bodily Pain (BP) | 0–90 (18.0–56.2) | 36.5 (33.5) | 24.1 (10.2) | ||
Global Health (GH) | 0–100 (14.2–63.8) | 38.3 (33.2) | 21.5 (10.7) | ||
Vitality (VI) | 0–85 (20.7–61.5) | 36.5 (38.2) | 23.2 (11.1) | ||
Role Emotional (RE) | 0–100 (25.4–55.7) | 35.7 (36.2) | 42.5 (12.9) | ||
Social Functioning (SF) | 0–100 (12.6–57.3) | 55.7 (37.5) | 30.6 (13.7) | ||
Mental Health (MH) | 0–100 (8.4–64.0) | 59.7 (41.6) | 23.4 (13.0) | ||
PCS | 13.7–55.0 | 31.7 | 9.7 | ||
MCS | 18.8–69.0 | 41.7 | 12.5 | ||